Dupixent: upcoming dates

Upcoming dates: 1 · All pins: 5

Next: Regeneron's Next Results: Q3 2026, Expected 30 October, October 30, 2026.

All Dupixent pins in search

Upcoming

Health10/05/2026@EconDesk
Regeneron's Next Results: Q3 2026, Expected 30 October
Regeneron Tarrytown Campus, Eastview, Town of Greenburgh, Westchester County, New York, United StatesRegeneron Pharmaceuticals
Starts 10/30/2026SCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins77% CONFIDENCEOverall confidence: 77%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or betterin 23 days
Regeneron's^[2] 24 September 2026 release (GlobeNewswire copy on Finviz^[1]) says it 'will report its third quarter 2026 financial and operating results on Friday, October 30, 2026, before the U.S. financial markets open' with a call at 8:30 AM Eastern Time.
Regeneron said on 24 September 2026 it will report third-quarter 2026 financial and operating results on Friday 30 October before US markets open, with a conference call and webcast at 8:30 a.m. Eastern.

Recent

Business10/04/2026@HealthDesk
Sanofi and Regeneron Expand Their Alliance With US$1 Billion Upfront
46-48 Avenue de la Grande Armée, Paris, FranceSanofi
Starts 10/01/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins86% CONFIDENCEOverall confidence: 86%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better6 days ago
Sanofi's^[1] press release is datelined "Paris and Tarrytown, NY, October 1, 2026" and the same release was furnished to the SEC^[3].
On 1 October 2026 Sanofi and Regeneron announced they will co-develop four new long-acting immunology antibodies; Regeneron receives US$1 billion upfront and up to US$7 billion more in milestones.
$1B

Related tags

Companies

Upcoming

Health10/05/2026@EconDesk

Regeneron's Next Results: Q3 2026, Expected 30 October

Regeneron Tarrytown Campus, Eastview, Town of Greenburgh, Westchester County, New York, United States

Regeneron Pharmaceuticals

Regeneron's Next Results: Q3 2026, Expected 30 October

Starts 10/30/2026SCHEDULED77% CONFIDENCEin 23 days

Regeneron's^[2] 24 September 2026 release (GlobeNewswire copy on Finviz^[1]) says it 'will report its third quarter 2026 financial and operating results on Friday, October 30, 2026, before the U.S. financial markets open' with a call at 8:30 AM Eastern Time.

Regeneron said on 24 September 2026 it will report third-quarter 2026 financial and operating results on Friday 30 October before US markets open, with a conference call and webcast at 8:30 a.m. Eastern.

Recent

Business10/04/2026@HealthDesk

Sanofi and Regeneron Expand Their Alliance With US$1 Billion Upfront

46-48 Avenue de la Grande Armée, Paris, France

Sanofi

Starts 10/01/2026CONFIRMED86% CONFIDENCE6 days ago

Sanofi's^[1] press release is datelined "Paris and Tarrytown, NY, October 1, 2026" and the same release was furnished to the SEC^[3].

On 1 October 2026 Sanofi and Regeneron announced they will co-develop four new long-acting immunology antibodies; Regeneron receives US$1 billion upfront and up to US$7 billion more in milestones.

$1B